Helvetia Holding AG (HBAN)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 22 Oct 2026
Key indicators
| Last close | CHF 217.20 |
|---|---|
| 52-week range | 183.40 – 226.60 |
| Return, 1 month / 3 months | −1.1% / +0.0% |
| Return, 1 year / 3 years | +15.2% / +108.6% |
| Trend | Uptrend |
| RSI (14) | 64 |
| Volatility (1 year) | 18.0% |
| Worst drawdown (1 year) | -11.9% |
| Average daily value traded | 27.25M CHF |
| Dividend yield | 3.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Helvetia Holding AG is a Swiss insurance group based in St. Gallen. It offers life and non-life insurance products to individuals and businesses, covering areas such as property, liability, accident and health cover, along with pension and savings solutions. The group also provides asset management and reinsurance services. Its main markets are Switzerland, Germany, Austria, Italy and Spain, where it serves private customers, small and medium-sized enterprises and larger corporate clients through its own sales forces and broker networks.
The shares are listed on the SIX Swiss Exchange in Switzerland under the code HBAN, and the price on this page is in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Helvetia Holding AG (HBAN) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 217.20 on 22 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 25 of 225 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 15.2% and over the last three months it rose 0.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 68 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 6.6% | ||
| From 52-week high | -3.6% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.0% | ||
| 6-month return | 2.0% | ||
| 12-month return, skipping the last month | 16.5% | ||
| Stability (higher is calmer) | 87 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 18.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -11.9% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 27.25M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 65 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.5% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +4.0% |
|---|---|
| 1 month | −1.1% |
| 3 months | +0.0% |
| 6 months | +2.0% |
| 1 year | +15.2% |
| 3 years | +108.6% |
| 5 years | +154.1% |
Signals
| 50-day / 200-day average | 211.86 / 203.85 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.08 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 May 2026 | CHF 7.7000 |
| 29 Apr 2025 | CHF 6.7000 |
| 28 May 2024 | CHF 6.3000 |
| 3 May 2023 | CHF 5.9000 |
| 3 May 2022 | CHF 5.5000 |
| 4 May 2021 | CHF 5.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.